These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28143527)

  • 1. Escape from IFN-γ-dependent immunosurveillance in tumorigenesis.
    Lin CF; Lin CM; Lee KY; Wu SY; Feng PH; Chen KY; Chuang HC; Chen CL; Wang YC; Tseng PC; Tsai TT
    J Biomed Sci; 2017 Feb; 24(1):10. PubMed ID: 28143527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion.
    Mojic M; Takeda K; Hayakawa Y
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL.
    Matsui S; Ahlers JD; Vortmeyer AO; Terabe M; Tsukui T; Carbone DP; Liotta LA; Berzofsky JA
    J Immunol; 1999 Jul; 163(1):184-93. PubMed ID: 10384115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironment abnormalities and lymphomagenesis: Immunological aspects.
    Taylor JG; Gribben JG
    Semin Cancer Biol; 2015 Oct; 34():36-45. PubMed ID: 26232774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do tumor stem cells actively escape from host immunosurveillance?
    Qi Y; Li RM; Kong FM; Li H; Yu JP; Ren XB
    Biochem Biophys Res Commun; 2012 Apr; 420(4):699-703. PubMed ID: 22465008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy.
    He YF; Wang XH; Zhang GM; Chen HT; Zhang H; Feng ZH
    Cancer Immunol Immunother; 2005 Sep; 54(9):891-7. PubMed ID: 15776283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.
    Castro F; Cardoso AP; Gonçalves RM; Serre K; Oliveira MJ
    Front Immunol; 2018; 9():847. PubMed ID: 29780381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon gamma in cancer immunotherapy.
    Ni L; Lu J
    Cancer Med; 2018 Sep; 7(9):4509-4516. PubMed ID: 30039553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets.
    Reva BA; Omelchenko T; Nair SS; Tewari AK
    Urol Clin North Am; 2020 Nov; 47(4S):e9-e16. PubMed ID: 33446324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L; Carbone DP
    Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocyte-derived TNF and IFN-γ repress HFE expression in cancer cells.
    Reuben A; Godin-Ethier J; Santos MM; Lapointe R
    Mol Immunol; 2015 Jun; 65(2):259-66. PubMed ID: 25700349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunobiology of cancer immunosurveillance and immunoediting.
    Dunn GP; Old LJ; Schreiber RD
    Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukemic T-cell-mediated immune reactions: limitations and perspectives for future therapies.
    Schmetzer HM
    Immunotherapy; 2011 Jul; 3(7):809-11. PubMed ID: 21751947
    [No Abstract]   [Full Text] [Related]  

  • 15. The Aryl Hydrocarbon Receptor and Tumor Immunity.
    Xue P; Fu J; Zhou Y
    Front Immunol; 2018; 9():286. PubMed ID: 29487603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.
    Chen J; Feng Y; Lu L; Wang H; Dai L; Li Y; Zhang P
    Immunobiology; 2012 Apr; 217(4):385-93. PubMed ID: 22204817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms.
    Demoulin S; Herfs M; Delvenne P; Hubert P
    J Leukoc Biol; 2013 Mar; 93(3):343-52. PubMed ID: 23136258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumoral activity of interferon-gamma involved in impaired immune function in cancer patients.
    Brandacher G; Winkler C; Schroecksnadel K; Margreiter R; Fuchs D
    Curr Drug Metab; 2006 Aug; 7(6):599-612. PubMed ID: 16918315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased accumulation of immune regulatory cells is correlated to the antitumor effect of IFN-γ overexpression in the tumor.
    Carrio R; Torroella-Kouri M; Libreros S; García-Areas RA; Iragavarapu-Charyulu V; López DM
    Int J Oncol; 2011 Dec; 39(6):1619-27. PubMed ID: 21874231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment.
    Huang Y; Wang HC; Zhao J; Wu MH; Shih TC
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.